REFERENCES
- Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure:The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446
- Setaro J F, Black H R. Refractory hypertension. N Engl J Med 1992; 327: 543–547
- Gifford R W. Resistant hypertension; introduction and definitions. Hypertension. 1988; 11: II65–II66
- Swales J D, Bing R F, Heagerty A, Pohl J EF, Russell G I, Thurston H. Treatment of refractory hypertension. Lancet. 1982; i: 894–896
- Alderman M H, Schoenbaum E E. Detection and treatment of hypertension at the work site. N Engl J Med 1975; 293: 65–68
- Yakovlevitch M, Black H R. Resistant hypertension in a tertiary care clinic. Arch Intern Med 1991; 151: 1786–1792
- Waeber J B, Scherrer U, Petrillo A. Are some hypertensive patients overtreated?A prospective study of ambulatory blood pressure monitoring. Lancet 1987; i: 732–734
- Pickering T G, James G D, Boddie C, et al. How common is white-coat hypertension?. JAMA 1988; 259: 225–228
- Myers M G, Reeves R A. White-coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991; 4: 844–849
- Mejia A D, Egan B M, Schork N J, Zweifler A J. Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment resistant hypertension. Ann Intern Med 1990; 112: 270–277
- Mezzetti A, Pierdomenico S D, Costantini F, Romano F, Bucci A, Di Gioacchino M. White-coat resistant hypertension. Am J Hypertens 1997; 10: 1302–1307
- Costa F V. Compliance with antihypertensive treatment.Clin and Exper Hyper. 1996; 18(3&4)463–472
- Weber M A. Strategies for improving blood pressure control. Am J Hypert 1998; 11: 897–899
- Sahn D J, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–83
- Devereux R B, Alonso D R, Lutas E M. Echocardiographic assessment of left ventricular hypertrophy : comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458
- Thijs L, Staessen J, Fagard R. Analysis of the diurnal blood pressure curve. High Blood Press 1992; 1: 17–28
- Veglio F, Rabbia F, Melchio R, Chiandussi L. Statistical evaluation of circadian blood pressure rhythm during isradipine long-term therapy. Eur J Clin Pharmacol 1994; 46: 119–122
- Pickering T G. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996; 9: 1–11
- Frohlich E D. Classification of resistant hypertension. Hypertension 1988; 11: II67–II70
- Alderman M H, Budner N, Cohen H, Lamport B, Ooi W L. Prevalence of drug resistant hypertension. Hypertension 1988; 11: II71–II75
- Parijs J, Joosens J V, Van der Linden L, Verstreken G, Amery A K. Moderate sodium restriction and diuretics in the treatment of hypertension. Am Heart J 1973; 85: 22–34
- Dustan H P, Tarazi R C, Bravo E L. Dependence of arterial pressure on intravascular volume in treated hypertensive patients. N Engl J Med 1972; 286: 861–866
- Dustan H P, Tarazi R C, Bravo E L. Diuretic and diet treatment of hypertension. Arch Intern Med 1974; 133: 1007–1013
- Arkwright P D, Beilin L J, Rouse I, Armstrong B K, Vandongen R. Effects of alcohol use and other aspects of lifestyle on blood pressure levels and prevalence of hypertension in a working population. Circulation 1982; 66: 60–66
- MacMahon S. Alcohol consumption and hypertension. Hypertension 1987; 9: 111–121
- Trenkwalder P, Plaschke M, Steffes-Tremer I, Lydtin H. White coat hypertension and alerting reaction in elderly and very elderly hypertensive patients. Blood Press 1993; 2: 262–271
- Rizzo V, Cicconetti P, Bianchi A, Lorido A, Morelli S, Vetta F, et al. White-coat hypertension and cardiac organ damage in elderly subjects. J Hum Hypertens 1996; 10: 293–298
- Taddei S, Virdis A, Mattei P, Duranti P, Favilla S, Salvetti A. Vascular renin-angiotensin system and sympathetic nervous system activity in human hypertension. J Cardiovasc Pharmacol 1994; 23(Suppl. I)S9–S14
- Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 3–17
- Saruta T, Kumagai H. The sympathetic nervous system in hypertension and renal disease. Current Opinion in Nephrology and Hypertension. 1996; 5: 72–79
- Tsuji M, Larson M G, Venditti F J, Manders E S, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94: 2850–2855
- Palatini P, Julius S. Association of tachycardia with morbidity and mortality : pathophysiological considerations. J Human Hypertens 1997; 11(Suppl I)S19–S27
- National High Blood Pressure Education Program Coordinating Committee.National High Blood Pressure Education Program Working Group report on ambulatory blood pressure monitoring. Arch Intern Med 1990; 159: 2270–2280
- Pickering T H. for an American Society of Hypertension Ad Hoc Panel. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypert 1995; 9: 1–11